Feb 17,2016

MindMaze, The World’s First Multisensory Computing Platform, Raises Commitments Of $100 Million In New Funding Round

MindMaze, the world’s first end-to-end multisensory computing platform, today announced it has raised commitments of $100 million in a new round led by the Hinduja Group, the 102-year-old global conglomerate that has invested since the company’s early stages, with participation from family offices. Also announcing its recent pre-money valuation of more than $1 billion, MindMaze will build further on its track record for launching top-end medical-grade neural virtual reality platforms.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 01,2016

WellDoc partners with J&J's LifeScan, raises $7.5 million more

Baltimore, Maryland-based WellDoc has announced a collaboration with LifeScan, a Johnson and Johnson company that makes blood glucose meters. WellDoc also raised an additional $7.5 million from Johnson & Johnson Innovation and other investors, bringing the company’s total funding in its most recent round to $29.5 million. WellDoc plans to work with LifeScan to integrate BlueStar, an FDA-cleared mobile application and program for people with Type II diabetes, with LifeScan’s OneTouch Verio Flex Bluetooth Smart blood glucose monitoring system and its companion app, OneTouch Reveal mobile app.

FUNDING SERIES B

#mobile app

View Analyst & Ambassador Comments
Go to original news
Apr 22,2016

Finnish health technology company Netmedi raises $940k seed funding

Netmedi, developer of the Kaiku Health platform, announced a $940k raise for its seed investment round. The financing round is being led by Jaakko Ollila from Metsola Ventures, private investor and founder of Med Group Kustaa Piha, Harri Tilev from T&T Nordcap along with significant participation from prior lead investor Reaktor Ventures.

FUNDING SEED
View Analyst & Ambassador Comments
Go to original news
Dec 06,2016

Arthro Therapeutics raises $2.2M for digital therapeutic for arthritis

Arthro Therapeutics, a Swedish startup creating digital therapeutics for the treatment of arthritis, has raised $2.2 million in seed funding. Sweet Capital led the round, and previous investors Dendera Ventures and Incos Invest also contributed. Several angel investors also pitched in, including Sophia Bendz, Hampus Jakobsson, and Tim Jackson. Lund University also contributed. The company had $1 million in funding already, so this brings its total funding to $3.2 million. Arthro's first product, Joint Academy, is a CE-marked digital version of an evidence-based program called "Better Management of OsteoArthritis" or BOA.

FUNDING SEED
View Analyst & Ambassador Comments
Go to original news
Mar 18,2015

Pear Therapeutics Closes Financing

Pear Therapeutics, the creator of prescription pharmaceutical-software combination products called eFormulations, announced today that it has successfully closed on additional financing. The funding round was led by 5AM Ventures, with several undisclosed additional investors contributing capital. The investment will allow Pear to build a portfolio of eFormulationsTM.

FUNDING FUNDING ROUND

#virtual reality

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 31,2015

LabStyle Innovations Closes $2.5 Million Funding to Support Global Rollout of Dario Diabetes Management Solution

LabStyle Innovations Corp., developer of the Dario Diabetes Management Solution, today announced it recently closed a round of funding totaling approximately $2.5 million. Funds will be used to support the global rollout and initial U.S. commercial launch of the Dario, a mobile, cloud-based, diabetes management solution that includes novel software applications combined with a stylish, 'all-in-one,' pocket-sized, blood glucose monitoring device, and for working capital purposes.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Nov 19,2015

LabStyle Innovations Closes $2.3 Million Round of Investment From Existing Shareholders and Private Investors

LabStyle Innovations Corp. today announced it has closed on an offering raising approximately $2.3 million in proceeds through the private placement of 7,648,267 shares of Common Stock and warrants to purchase 7,648,267 shares of Common Stock with existing shareholders and private investors including a member of the Company's board of directors, employees and a Dario distributor.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Apr 09,2014

Omada Health Closes $23 Million Series B Financing Led by Andreessen Horowitz

Omada Health, a pioneer in the emerging field of digital therapeutics, today announced it has closed $23 million in Series B financing led by Andreessen Horowitz, with participation from Kaiser Permanente Ventures and existing investors including U.S. Venture Partners and The Vertical Group. In addition, Andreessen Horowitz general partner, Balaji S. Srinivasan, will be joining Omada Health’s board of directors.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Sep 04,2014

Propeller Health Raises $14.5 Million Series B Financing Led by Safeguard Scientifics

Propeller Health, the FDA-cleared digital health solution for chronic respiratory disease, today announced that it raised $14.5 million in Series B financing, led by Safeguard Scientifics (NYSE:SFE) with participation from Series A investor The Social+Capital Partnership. Propeller Health will use the funding to accelerate product development, strategic alliances, client services, sales and marketing.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Sep 18,2014

Omada Health raises $950K to serve low income populations

San Francisco-based Omada Health has received $950,000 from the California Health Care Foundation (CHCF) and The Kresge Foundation to expand its prediabetes program, called Prevent, to low income populations in the US. Omada Health will use the funds to conduct Prevent pilots in certain low income clinics. The company also said they would increase access to Prevent "amongst Medicaid plans nationwide".

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING